National Association of Testing Authorities, Australia
Scope of Accreditation
Victorian Infectious Diseases Reference Laboratory
Site
Victorian Infectious Diseases Reference Laboratory
Accreditation No.
2576
Site No.
2569
Date of Accreditation
08 Mar 1989
Contact
Ms Diana Piccoli
P: +61 (03) 93429644
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Bacteriology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 Oct 2023
Last Activity Date
10 May 2021
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Biopsy specimens; Bronchoalveolar lavage; Bronchoalveolar washings; Fluids; Respiratory specimens; Sputum; Tissues | Legionella pneumophila; Cultured pathogens identification |
| Bacterial isolates | Cultured pathogens identification | |
| Blood | Bacteria | |
| Cerebrospinal fluid (CSF); Urine | Streptococcus pneumoniae | |
| Cervical swabs; Genital swabs; Rectal swabs; Urethra; Vaginal swabs | Pathogenic identification and antibiotic susceptibility | |
| Ear swabs; Eye swabs; Nasal swabs; Throat swabs | Antibiotic susceptibility; Cultured pathogens identification | |
| Faeces | Clostridioides difficile toxin | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Aspirates; Cerebrospinal fluid (CSF); Eye swabs; Fluids; Genital swabs; Meatal swabs; Plasma; Rectal swabs; Serum; Throat swabs; Tissues; Urethral swabs; Urine | Chlamydia trachomatis; Mycoplasma genitalium; Neisseria gonorrhoeae |
| Bronchial washings; Bronchoalveolar lavage; Nasopharyngeal aspirate; Sputum; Sterile site | Legionella longbeachae; Legionella pneumophila | |
| Cerebrospinal fluid (CSF) | Treponema pallidum | |
| Cervical specimen; Genital swabs; Rectal swabs; Urine | Neisseria gonorrhoeae | |
| Cervical specimen; Urine; Vaginal swabs | Neisseria gonorrhoeae | |
| Cervical swabs; Urine; Vaginal swabs | Chlamydia trachomatis; Mycoplasma genitalium; Neisseria gonorrhoeae | |
| Faeces; Tissues | Aeromonas spp.; Campylobacter spp.; Clostridium difficile toxin B; Escherichia coli - Enteroinvasive (EIEC); Salmonella spp.; Shigella spp.; Vibrio spp.; Yersinia enterocolitica | |
| Fluids; Genital swabs; Nasopharyngeal swabs; Rectal swabs; Tissues; Urethral swabs | Neisseria gonorrhoeae | |
| Genital swabs; Urine | Mycoplasma genitalium | |
| Plasma; Serum; Urine | Leptospira spp. | |
| Tissues | Legionella longbeachae; Legionella pneumophila; Treponema pallidum | |
| Vaginal swabs | Gardnerella vaginalis | |
| Wound swabs | Treponema pallidum | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Bronchial washings; Bronchoalveolar lavage | Aspergillus spp. |
| Bronchial washings; Bronchoalveolar lavage; Sputum | Pneumocystis jirovecii | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (helminth parasites) | Faeces | Ancylostoma duodenale; Ascaris spp. (roundworm); Enterobius vermicularis; Hymenolepis diminuta; Hymenolepis nana; Necator americanus; Strongyloides stercoralis; Taenia multiceps; Taenia saginata; Taenia solium; Trichuris trichiura |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Blood | Plasmodium falciparum; Plasmodium knowlesi; Plasmodium malariae; Plasmodium ovale curtisi; Plasmodium ovale wallikeri; Plasmodium vivax |
| Cervical swabs; Urine; Vaginal swabs | Trichomonas vaginalis | |
| Faeces | Blastocystis hominis; Cryptosporidium spp.; Cyclospora cayetanensis; Dientamoeba fragilis; Entamoeba histolytica; Giardia lamblia | |
| Genital swabs; Urine | Trichomonas vaginalis | |
| Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation | Blood | Mycobacterial antigen lymphocyte stimulation |
| Microbiology - Mycology - Detection of dermatophytes and other fungi causing cutaneous disease | Nails; Skin scrapings | Dermatophyte identification |
| Microbiology - Mycology - Detection, isolation and identification of yeasts and fungal elements | Bronchial lavage; Serum | Isolation of yeasts and Aspergillus |
| Cerebrospinal fluid (CSF); Serum | Cryptococcus antigen | |
| Isolates | Fungi susceptibility; Yeast susceptibility | |
| Nails; Skin scrapings | Fungi identification | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Microfilaria; Malaria |
| Eye swabs; Faeces; Sputum; Tissues; Urine | Microsporidia | |
| Faeces | Parasites | |
| Cryptosporidia | ||
| Semen; Urine | Ova | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Urine | Legionella pneumophila serogroup 1 antibody |
Enteric Viruses Reference Laboratory
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 Oct 2023
Last Activity Date
10 May 2021
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Faeces; General swabs; Isolates; Nucleic acid | Enterovirus |
| Isolates | Poliovirus | |
| Microbiology - Molecular biology - Microbial genotyping | Faeces; Nucleic acid; Vomitus | Norovirus |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood; Plasma; Serum | Poliovirus type 1/2/3 |
| Microbiology - Serology of infection - Microbial typing | Faeces; Isolates; Nucleic acid; Swabs | Enterovirus typing |
| Microbiology - Virology - Detection of pathogenic viruses | Faeces; General swabs; Isolates | Enterovirus |
HIV Characterisation
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 Oct 2023
Last Activity Date
10 May 2021
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Blood | Human T-lymphotropic virus type II (HTLV-II); Human T-lymphotropic virus type I (HTLV-I); Human immunodeficiency virus (HIV) DNA; Human immunodeficiency virus type 2 (HIV-2) DNA |
| Blood; Cerebrospinal fluid (CSF); Plasma; Serum | Human immunodeficiency virus type 1 (HIV-1) RNA | |
| Blood; Plasma | Human immunodeficiency virus type 1 (HIV-1) RNA | |
| Human immunodeficiency virus type 1 (HIV-1) RNA | ||
| Human immunodeficiency virus type 2 (HIV-2) RNA | ||
| Cerebrospinal fluid (CSF); Serum | Human immunodeficiency virus type 1 (HIV-1) RNA | |
| Microbiology - Molecular biology - Microbial genotyping | Blood | Human immunodeficiency virus type 1 (HIV-1) proviral DNA |
| Blood; Cerebrospinal fluid (CSF); Plasma; Serum | Human immunodeficiency virus (HIV) co-receptor tropism genotype; Human immunodeficiency virus type 1 (HIV-1) sequencing for drug resistance | |
| Blood; Plasma | Human immunodeficiency virus type 1 (HIV-1) sequencing for drug resistance | |
| Plasma | Human immunodeficiency virus type 1 (HIV-1) sequencing for drug resistance | |
| Microbiology - Molecular biology - Quantitation of microbial nucleic acids | Blood | Human T-lymphotropic virus (HTLV) viral load |
| Blood; Plasma | Human immunodeficiency virus (HIV) RNA viral load | |
| Human immunodeficiency virus (HIV) RNA viral load | ||
| Cerebrospinal fluid (CSF); Serum | Human immunodeficiency virus (HIV) RNA viral load | |
| Plasma | Human immunodeficiency virus (HIV) RNA viral load |
Molecular Microbiology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 Oct 2023
Last Activity Date
10 May 2021
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Blood; Cerebrospinal fluid (CSF); Plasma; Serum; Tissues; Urine | BK virus |
| Blood; Cerebrospinal fluid (CSF); Serum; Tissues; Urine | John Cunningham virus (JC) | |
| Blood; Cerebrospinal fluid (CSF); Urine | BK virus | |
| John Cunningham virus (JC) | ||
| Blood; Serum | Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA | |
| Hepatitis E virus (HEV) | ||
| Hepatitis A virus (HAV) | ||
| Hepatitis B virus (HBV) DNA | ||
| Hepatitis D virus (HDV) | ||
| Blood; Serum; Tissues | Hepatitis A virus (HAV); Hepatitis E virus (HEV) | |
| Blood; Urine | John Cunningham virus (JC) | |
| Plasma; Serum | Hepatitis B virus (HBV) DNA | |
| Hepatitis C virus (HCV) sequencing for antiviral resistance | ||
| Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA | ||
| Microbiology - Molecular biology - Microbial genotyping | Plasma; Serum | Hepatitis C virus (HCV) subtypes |
| Serum | Hepatitis C virus (HCV) subtypes | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Hepatitis B virus surface antigen (HBs Ag) |
Mycobacterium Reference Laboratory (MRL)
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 Oct 2023
Last Activity Date
10 May 2021
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Ascitic fluid; Aspirates; Bacterial isolates; Cerebrospinal fluid (CSF); Gastrointestinal fluid; Lymph node fluid; Nasopharyngeal aspirate; Paraffin embedded tissue; Pericardial fluid; Peritoneal fluid; Pleural fluid; Pus; Respiratory specimens; Tissues | Mycobacterium tuberculosis complex; Mycobacterium rifampicin resistance rpoB |
| Ascitic fluid; Aspirates; Blood; Bone marrow; Cerebrospinal fluid (CSF); Faeces; Gastrointestinal fluid; General swabs; Lymph node fluid; Nasopharyngeal aspirate; Paraffin embedded tissue; Pericardial fluid; Peritoneal fluid; Pleural fluid; Pus; Respiratory specimens; Tissues | Mycobacterium tuberculosis complex | |
| Ascitic fluid; Aspirates; Blood; Bone marrow; Cerebrospinal fluid (CSF); Gastrointestinal fluid; General swabs; Lymph node fluid; Nasopharyngeal aspirate; Paraffin embedded tissue; Pericardial fluid; Peritoneal fluid; Pleural fluid; Pus; Respiratory specimens; Tissues | Mycobacterium spp. | |
| Bacterial isolates | Mycobacterium tuberculosis complex | |
| General swabs; Nasal secretions; Paraffin embedded tissue; Pus; Respiratory specimens; Skin scrapings; Tissues | Mycobacterium leprae | |
| General swabs; Paraffin embedded tissue; Tissues | Mycobacterium ulcerans | |
| Isolates | Mycobacterium avium complex (MAC) | |
| Sputum | Mycobacterium tuberculosis complex; Mycobacterium rifampicin resistance rpoB | |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Ascitic fluid; Aspirates; Bone marrow; Faeces; Gastrointestinal fluid; Lymph node fluid; Other body fluids; Pericardial fluid; Peritoneal fluid; Pus; Respiratory specimens; Tissues | Mycobacteria detection; Mycobacteria identification |
| Aspirates; Bone marrow; Cerebrospinal fluid (CSF); Faeces; Gastric lavage; Other body fluids; Respiratory specimens; Tissues | Mycobacteria antibiotic susceptibility; Mycobacteria detection; Mycobacteria identification | |
| Blood; Bone marrow | Mycobacteria detection | |
| Isolates | Mycobacteria antibiotic susceptibility | |
| Mycobacteria antibiotic susceptibility |
Serology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 Oct 2023
Last Activity Date
10 May 2021
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Cadaveric blood | Hepatitis C virus antibody (anti-HCV) |
| Hepatitis B virus surface antigen (HBs Ag); Hepatitis B virus surface antigen (HBs Ag) - Confirmatory; Hepatitis B virus surface antigen (HBs Ag) neutralisation | ||
| Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen | ||
| Cerebrospinal fluid (CSF) | Human immunodeficiency virus (HIV) | |
| Japanese encephalitis virus (JEV) | ||
| Measles IgG antibody; Measles IgM antibody | ||
| Syphilis Treponema pallidum total antibody | ||
| Syphilis Treponema pallidum antibody | ||
| Human immunodeficiency virus (HIV) p24 antigen; Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen | ||
| Syphilis Treponema pallidum IgM antibody | ||
| Cerebrospinal fluid (CSF); Plasma; Serum | Varicella zoster virus IgG antibody; Varicella zoster virus IgM antibody | |
| Cerebrospinal fluid (CSF); Serum | Murray Valley encephalitis virus | |
| Plasma; Serum | Brucella abortus IgG antibody; Brucella abortus IgM antibody; Syphilis Treponema pallidum IgM antibody | |
| Hepatitis B virus core antibody (anti-HBc) - IgM | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) antibody | ||
| Mumps virus IgG antibody; Mumps virus IgM antibody | ||
| Herpes simplex virus (HSV) IgG; Herpes simplex virus (HSV) IgM | ||
| Human immunodeficiency virus (HIV) p24 antigen; Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen | ||
| Human T-lymphotropic virus type I/II (HTLV-I/II) | ||
| Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus (HCV); Hepatitis C virus antibody (anti-HCV) - IgG | ||
| Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis A virus antibody (anti-HAV) - Total | ||
| Taenia solium | ||
| Dengue virus NS1 antigen | ||
| Coxiella burnetii (Q-fever) IgM phase 2 antibody; Hantavirus IgG | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgG antibody | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) total antibody | ||
| Hepatitis E virus (HEV) IgG | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgM antibody; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) total antibody | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) antibody | ||
| Cytomegalovirus (CMV) IgG avidity; Cytomegalovirus antibody (anti-CMV) IgG; Cytomegalovirus antibody (anti-CMV) IgM; Epstein-Barr virus nuclear antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgM antibody; Human immunodeficiency virus (HIV); Measles IgG antibody; Measles IgM antibody | ||
| Dengue virus IgG antibody; Dengue virus IgM antibody | ||
| Measles IgG antibody; Measles IgM antibody; Rubella IgG antibody; Rubella IgM antibody; Zika virus IgG antibody; Zika virus IgM antibody | ||
| Hepatitis C virus antibody (anti-HCV) | ||
| Entamoeba histolytica IgG antibody; Epstein-Barr virus nuclear antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgM antibody; Measles IgG antibody; Measles IgM antibody; Parvovirus B19 IgG antibody; Parvovirus B19 IgM antibody | ||
| Measles virus IgG avidity | ||
| Hepatitis C virus antibody (anti-HCV) - IgG | ||
| Adenovirus IgA antibody; Adenovirus IgG antibody | ||
| Herpes simplex virus type 2 antibody (anti-HSV2) - IgG; Herpes simplex type 1 antibody (anti-HSV1) - IgG | ||
| Human immunodeficiency virus (HIV) | ||
| Human T-lymphotropic virus type I/II (HTLV-I/II) | ||
| Serum | Japanese encephalitis virus (JEV); Toxoplasma spp. IgG antibody; Toxoplasma spp. IgM antibodyToxo serology by euroimmun added in June 2021 review next RES 2023 | |
| Syphilis Treponema pallidum total antibody | ||
| Kunjin virus | ||
| Chlamydial spp. IgG antibody; Chlamydial spp. IgG antigen; Chlamydial group IgA antibody | ||
| Influenza A virus; Influenza B virus | ||
| Mycoplasma pneumoniae IgM antibody; Mycoplasma total antibody | ||
| Syphilis Treponema pallidum antibody | ||
| Yellow fever virus | ||
| Ross River virus IgG antibody; Ross River virus IgM antibody | ||
| Rubella IgM antibody | ||
| Rickettsia rickettsii; Rickettsia typhi | ||
| Respiratory syncytial virus (RSV) total antibody | ||
| Rubella IgG antibody; Rubella IgM antibody | ||
| Coxiella burnetii (Q-fever) IgG phase 2 antibody; Coxiella burnetii (Q-fever) IgM phase 2 antibody; Coxiella burnetii (Q-fever) phase 1 total antibody; Coxiella burnetii (Q-fever) phase 2 total antibody | ||
| Chikungunya IgG antibody; Chikungunya IgM antibody; Hantavirus IgM | ||
| Coronavirus SARS; Coronavirus; Flavivirus; Legionella spp.; Murray Valley encephalitis virus | ||
| Leishmaniasis | ||
| Human herpes virus type 6 (HHV6) IgG antibody; Human herpes virus type 6 (HHV6) IgM antibody | ||
| Rubella IgM antibody | ||
| Strongyloides IgG antibody | ||
| Schistosoma mansoni total antibody | ||
| Helicobacter pylori IgG antibody | ||
| Barmah forest virus IgG antibody; Barmah forest virus IgM antibody | ||
| Echinococcus granulosus total antibody | ||
| Hepatitis D virus (HDV) | ||
| Orientia tsutsugamushi virus (scrub typhus) IgM antibody; Orientia tsutsugamushi virus (scrub typhus) IgG antibody | ||
| Legionella spp. |
Virus Identification
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 Oct 2023
Last Activity Date
10 May 2021
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Aspirates; Bacterial isolates; Blood; Bone marrow; Bronchial washings; Bronchoalveolar lavage; Brushings; Cerebrospinal fluid (CSF); Faeces; Fluids; Fresh biopsy; General swabs; Human breast milk; Intestinal contents; Lavage; Nucleic acid; Paraffin embedded tissue; Plasma; Saliva; Scrapings; Semen; Serum; Sputum; Tissues; Urine | Chlamydophila psittaci |
| Chlamydophila pneumoniae | ||
| Mycoplasma pneumoniae | ||
| Bordetella pertussis | ||
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Aspirates; Blood; Bone marrow; Bronchial washings; Bronchoalveolar lavage; Brushings; Cerebrospinal fluid (CSF); Faeces; Fluids; Fresh biopsy; General swabs; Human breast milk; Intestinal contents; Isolates; Lavage; Nucleic acid; Plasma; Saliva; Scrapings; Semen; Serum; Sputum; Tissues; Urine | Toxoplasma gondii |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | 3D printed swabs; Flocked saliva swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Aspirates; Blood; Bone marrow; Bronchial lavage; Bronchial washings; Bronchoalveolar lavage; Brushings; Cerebrospinal fluid (CSF); Faeces; Fluids; Fresh biopsy; General swabs; Human breast milk; Intestinal contents; Isolates; Lavage; Nucleic acid; Paraffin embedded tissue; Plasma; Saliva; Scrapings; Semen; Serum; Sputum; Tissues; Urine | Cytomegalovirus (CMV) sequencing | |
| Middle Eastern respiratory syndrome coronavirus (MERS-CoV) | ||
| Enterovirus | ||
| Sabia virus | ||
| Human parechovirus | ||
| Monkeypox virus; Orthopox virus group; Smallpox virus | ||
| Cytomegalovirus (CMV); Herpes simplex virus type 1 (HSV1); Herpes simplex virus type 2 (HSV2); Varicella zoster virus (VZV) | ||
| Monkeypox virus | ||
| Cowpox virus; Cytomegalovirus (CMV); Monkeypox virus; Orthopox virus group; Parapox virus; Smallpox virus; Yatapox virus | ||
| Respiratory syncytial virus (RSV) | ||
| Influenza A virus typing | ||
| Human herpes virus type 6 (HHV6) | ||
| Herpes simplex virus (HSV) phenotyping | ||
| Parainfluenza virus type 1/2/3 | ||
| Junin virus | ||
| Japanese encephalitis virus (JEV) | ||
| Sindbis virus | ||
| Flavivirus | ||
| Hantavirus | ||
| Alphavirus | ||
| Rabies virus genus | ||
| Toscana virus | ||
| Hendra virus | ||
| Chikungunya virus - Mauritius strain | ||
| Mumps virus | ||
| Coxsackie virus | ||
| Varicella zoster virus - Vaccine strain | ||
| Rift Valley fever virus | ||
| Parvovirus B19 | ||
| Dengue virus | ||
| Picornavirus | ||
| Cowpox virus | ||
| Herpesvirus simiae (Herpes virus B) | ||
| Rubella virus | ||
| Echovirus | ||
| Molluscum contagiosum virus | ||
| Measles virus | ||
| Orf virus; Parapox virus | ||
| Crimean-Congo hemorrhagic fever virus (CCHF) | ||
| Human metapneumovirus | ||
| Alphavirus | ||
| Epstein-Barr virus | ||
| Coronavirus SARS | ||
| Kunjin virus | ||
| Tanapox virus | ||
| Ebola virus | ||
| Coronavirus | ||
| Epstein-Barr virus - Quantitative | ||
| Lassa virus | ||
| Adenovirus | ||
| Cytomegalovirus (CMV) | ||
| Guanarito virus | ||
| Varicella zoster virus (VZV) | ||
| Human herpes virus type 7 (HHV7) | ||
| Rabies virus | ||
| Lymphocytic choriomeningitis virus | ||
| Human herpes virus type 8 (HHV8) | ||
| Nipah virus | ||
| Influenza A virus | ||
| Marburg virus | ||
| Yatapox virus | ||
| Cytomegalovirus (CMV) - Quantitative | ||
| Faeces; Intestinal contents | Norovirus | |
| Nasal aspirates/washes; Nasal swabs; Nasopharyngeal swabs; Oropharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Nasopharyngeal swabs; Oropharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Respiratory swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Vomitus | Norovirus | |
| Microbiology - Molecular biology - Microbial genotyping | Aspirates; Blood; Bone marrow; Bronchial lavage; Bronchial washings; Bronchoalveolar lavage; Brushings; Cerebrospinal fluid (CSF); Faeces; Fluids; Fresh biopsy; General swabs; Human breast milk; Intestinal contents; Isolates; Lavage; Nucleic acid; Paraffin embedded tissue; Plasma; Saliva; Scrapings; Semen; Serum; Sputum; Tissues; Urine | Enterovirus |
| Alphavirus | ||
| Aspirates; Blood; Bone marrow; Brushings; Cerebrospinal fluid (CSF); Faeces; Fluids; Fresh biopsy; General swabs; Human breast milk; Intestinal contents; Isolates; Lavage; Nucleic acid; Paraffin embedded tissue; Plasma; Saliva; Scrapings; Semen; Serum; Sputum; Tissues; Urine; Washings | Murray Valley encephalitis virus | |
| Measles virus genotyping | ||
| Parechovirus | ||
| Ross River virus | ||
| Herpes simplex virus (HSV) | ||
| Yellow fever virus | ||
| Measles virus genotyping | ||
| Cytomegalovirus (CMV) | ||
| Flavivirus | ||
| Varicella zoster virus genotyping | ||
| Microbiology - Molecular biology - Surveillance programme for the detection of microbial nucleic acids (viruses) in accordance with Commonwealth and/or State Health protocols | Saliva | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
WHOCCRRI
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 Oct 2023
Last Activity Date
10 May 2021
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Isolates; Nasal swabs; Nasopharyngeal aspirate; Sputum; Throat swabs; Tissues | Influenza A virus; Influenza B virus |
| Isolates; Nasal swabs; Nasopharyngeal aspirate; Throat swabs; Tissues | Influenza A virus; Influenza A virus H1/H; Influenza B virus; Influenza virus H1N1 - Swine |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2576
Site No.
2569
Print date
22 Jan 2022
END OF SCOPE